BioInnovation Capital I LP is a venture capital fund based in Cambridge, Massachusetts. According to its most recent Form D, filed Feb 15, 2017, it has sold $65,625,000 of interests to 12 investors since its first sale in Feb 2016. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include General Partner BioInnovation Capital I GP LLC.
- Total raised
- $65,625,000Cumulative sales reported on Form D
- Investors
- 12
- First sale
- Feb 23, 2016
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- General Partner BioInnovation Capital I GP LLC
- Latest Form D
- Feb 15, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Feb 15, 2017 | Form D/A (amendment) | $65,625,000 | 12 | SEC.gov ↗ |
| Feb 4, 2016 | Form D | $0 | 0 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Feb 4, 2016. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about BioInnovation Capital I LP
What is the minimum investment for BioInnovation Capital I LP?
BioInnovation Capital I LP's latest Form D, filed Feb 15, 2017, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in BioInnovation Capital I LP?
BioInnovation Capital I LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has BioInnovation Capital I LP raised?
BioInnovation Capital I LP reports $65,625,000 sold from 12 investors on its Form D filed Feb 15, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is BioInnovation Capital I LP based?
BioInnovation Capital I LP is based in Cambridge, Massachusetts.
When did BioInnovation Capital I LP launch?
BioInnovation Capital I LP reports its first sale in Feb 2016.
Size compared with every venture capital fund
Raised more than 92% of the 533 venture capital funds based in Massachusetts, and more than 97% of all 14,901 that report sales.